The demand for safe transfusion blood is driven by the rising
global prevalence of blood disorders, increased incidents of road
accidents and surgeries, and the growing geriatric population.
WILMINGTON, Del., July 25,
2024 /PRNewswire/ -- The global blood transfusion
diagnostics market stood at US$ 4.6
billion in 2023, and the global market is projected to
reach US$ 7.7 billion in 2034.
The global blood transfusion diagnostics market is anticipated to
expand at a CAGR of 4.9% between 2024 and 2034.
The rising global prevalence of blood disorders, such as anemia,
hemophilia, and leukemia, necessitates the need for accurate and
reliable diagnostic tests to assess blood compatibility and
identify potential risks associated with transfusions.
Additionally, the surge in road accidents and surgical
procedures further drives the demand for blood transfusions,
emphasizing the importance of stringent screening and compatibility
testing to prevent adverse reactions and ensure patient safety.
Moreover, the growing geriatric population, who are more prone
to chronic illnesses and require frequent medical interventions,
contributes to the escalating demand for blood transfusion
diagnostics.
Download Sample PDF
Brochure:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85892
Elderly individuals often require blood transfusions as part of
their treatment regimens, underscoring the critical role of
diagnostic tests in assessing blood suitability and minimizing
transfusion-related complications.
Furthermore, the increasing focus on collaborations and
partnerships between healthcare entities and research institutions
plays a pivotal role in expanding the adoption of advanced blood
transfusion diagnostics.
These collaborations aim to enhance diagnostic technologies,
develop innovative testing methodologies, and streamline
transfusion protocols to improve patient outcomes and ensure the
safety and efficacy of blood transfusions.
Technological advancements in blood transfusion diagnostics,
such as the development of automated platforms, molecular testing
techniques, and point-of-care devices, further drive market growth
by offering rapid, accurate, and cost-effective testing
solutions.
The innovative technologies enable healthcare professionals to
perform comprehensive blood compatibility assessments, detect
infectious agents, and identify potential immunological reactions
more efficiently, thereby facilitating timely and informed
transfusion decisions.
The blood transfusion diagnostics market is poised for continued
expansion as the demand for safe and effective transfusion
practices escalates worldwide. With ongoing advancements in
diagnostic technologies and increased collaboration efforts within
the healthcare industry, the market is expected to witness
significant growth opportunities in the coming years, ensuring the
delivery of high-quality transfusion services and improving patient
care outcomes.
Blood Transfusion Diagnostics Market Report
Scope:
Report
Coverage
|
Details
|
Forecast
Period
|
2024-2034
|
Base
Year
|
2020-2022
|
Size in 2023
|
US$ 4.6 Bn
|
Forecast (Value) in
2034
|
US$ 7.7 Bn
|
Growth Rate
(CAGR)
|
4.9 %
|
No. of
Pages
|
225
Pages
|
Segments
covered
|
By Product Type, By
Application, By Region, By End-user
|
Key Takeaways of Market Report
- Global blood transfusion diagnostics market to generate
absolute dollar opportunity worth US$ 7.7
billion until 2034.
- Global blood transfusion diagnostics market is valued at
US$ 4.6 billion in 2023.
- North America is forecasted to
hold the largest market share.
Global Blood Transfusion Diagnostics Market: Growth
Drivers
- Technological advancements in blood donor management systems,
particularly the emergence of automated systems, have
revolutionized workflows, enhancing efficiency and accuracy.
- Donor recruitment and engagement technologies, including
innovative software and mobile applications, play a pivotal role in
reaching potential donors, scheduling appointments, sending
reminders, and providing post-donation care instructions. This
improves donor engagement, enhances the overall donor experience,
and boosts donor retention rates.
- The increasing prevalence of blood-related disorders like
leukemia, thalassemia, sickle cell anemia, and hemophilia drives
the demand for safe transfusion blood, fueling the growth of the
blood transfusion diagnostics market.
Global Blood Transfusion Diagnostics Market: Regional
Landscape
- North America held a dominant
share in the blood transfusion diagnostics market, driven by
advancements in healthcare infrastructure, increased awareness, and
augmented healthcare finances. In the
United States, companies like Roche are launching innovative
transfusion diagnostics solutions, such as the cobas Malaria test,
FDA-approved in March 2024, to reduce
the risk of malarial infection from transfused blood products.
- In the European Union, the rising prevalence of diseases like
sickle cell anemia is spurring efforts by medical device
manufacturers and the government to improve transfusion blood
availability, thereby driving market growth in Europe.
Request Table of Content Here:
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=85892
Global Blood Transfusion Diagnostics Market: Key
Players
- In 2023, Prestige Diagnostics introduced a cutting-edge blood
transfusion diagnostics platform designed to enhance the accuracy
and efficiency of blood compatibility testing. This innovative
solution incorporates advanced molecular testing techniques and
automated workflows to streamline the transfusion process, ensuring
compatibility and safety for patients receiving blood
transfusions.
- In 2023, Atlas Medical launched a revolutionary point-of-care
blood transfusion diagnostics device capable of rapid and reliable
testing for blood type compatibility and infectious diseases. This
portable device enables healthcare professionals to perform on-site
testing with minimal turnaround time, facilitating timely and
informed transfusion decisions and improving patient outcomes in
diverse healthcare settings.
Global Blood Transfusion Diagnostics Market:
Segmentation
Product Type
- Instruments
- Blood Grouping Instruments
- Others
- Kits and Reagents
- Blood Grouping Kits and Reagents
- Others
Application
- Blood Grouping
- ABO Blood Grouping
- Rh Blood Grouping
- Red Blood Cell Antibody Screening
- Extended Phenotyping
- Cross Matching Tests
- Disease Screening
- Molecular Disease Screening
- Serological Disease Screening
End User
- Blood Banks
- Blood Donation/Transfusion Centers
- Others
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Purchase the Report for Market-Driven
Insights:
https://www.transparencymarketresearch.com/checkout.php?rep_id=85892<ype=S
Have a Look at More Valuable Insights of Healthcare
- Insufflation Devices Market: The global market
for insufflation devices was estimated to be worth US$ 2.3 billion in 2021. The market is
anticipated to advance with a 6.7% CAGR from 2022 to 2031
and by 2031; the market is likely to gain US$ 4.7 billion.
- Endodontic Files Market: The market for
endodontic files was worth US$ 22.5
million in 2022. A 6.1% CAGR is expected from
2022 to 2032. The market is projected to reach US$ 40.7 million by 2032.
- On-body Drug Delivery Devices Market is expected to grow
at a CAGR of 6.8% from 2024 to 2034 and reach US$ 796.1 Mn by the end of 2034
About Transparency Market Research
Transparency Market Research, a global market research
company registered at Wilmington,
Delaware, United States,
provides custom research and consulting services. Our exclusive
blend of quantitative forecasting and trends analysis provides
forward-looking insights for thousands of decision makers. Our
experienced team of Analysts, Researchers, and Consultants use
proprietary data sources and various tools & techniques to
gather and analyses information.
Our data repository is continuously updated and revised by a
team of research experts, so that it always reflects the latest
trends and information. With a broad research and analysis
capability, Transparency Market Research employs rigorous primary
and secondary research techniques in developing distinctive data
sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE
HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware
19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free:
866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter|
Blog | YouTube
Logo:
https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/blood-transfusion-diagnostics-market-to-attain-a-valuation-of-us-7-7-billion-by-2034--rising-global-prevalence-of-blood-disorders-drives-growth-transparency-market-research-302205251.html
SOURCE Transparency Market Research